192 related articles for article (PubMed ID: 34155756)
1. Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.
Kanjanapan Y; Blinman P; Underhill C; Karikios D; Segelov E; Yip D
Intern Med J; 2021 Jun; 51(6):955-959. PubMed ID: 34155756
[TBL] [Abstract][Full Text] [Related]
2. Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.
Gundavda MK; Gundavda KK
Curr Treat Options Oncol; 2021 Sep; 22(10):95. PubMed ID: 34515857
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N
Intern Med J; 2021 May; 51(5):763-768. PubMed ID: 34047035
[TBL] [Abstract][Full Text] [Related]
4. Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.
Romano E; Pascolo S; Ott P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117117
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.
Nigro O; Sironi G; Bergamaschi L; Gattuso G; Puma N; Livellara V; Chiaravalli S; Ferrari A; Massimino M
Pediatr Blood Cancer; 2021 Oct; 68(10):e29240. PubMed ID: 34264546
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and oncological disease.
Šálek T; Slopovský J; Pörsök Š; Pazderová N; Mináriková Z; Zomborská E; Špánik B
Klin Onkol; 2021; 34(3):211-219. PubMed ID: 34362259
[TBL] [Abstract][Full Text] [Related]
8. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
9. Cancer Centers, Organizations Call for COVID-19 Vaccine for Patients With Cancer, Survivors.
Printz C
Cancer; 2021 Apr; 127(8):1170-1171. PubMed ID: 33878201
[No Abstract] [Full Text] [Related]
10. An Open Letter: COVID-19 and Cancer.
Printz C
Cancer; 2021 Apr; 127(8):1171. PubMed ID: 33878202
[No Abstract] [Full Text] [Related]
11. COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Desai A; Gainor JF; Hegde A; Schram AM; Curigliano G; Pal S; Liu SV; Halmos B; Groisberg R; Grande E; Dragovich T; Matrana M; Agarwal N; Chawla S; Kato S; Morgan G; Kasi PM; Solomon B; Loong HH; Park H; Choueiri TK; Subbiah IM; Pemmaraju N; Subbiah V;
Nat Rev Clin Oncol; 2021 May; 18(5):313-319. PubMed ID: 33723371
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care.
Carr E
Clin J Oncol Nurs; 2021 Feb; 25(1):76-84. PubMed ID: 33480870
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
14. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Weinkove R; McQuilten ZK; Adler J; Agar MR; Blyth E; Cheng AC; Conyers R; Haeusler GM; Hardie C; Jackson C; Lane SW; Middlemiss T; Mollee P; Mulligan SP; Ritchie D; Ruka M; Solomon B; Szer J; Thursky KA; Wood EM; Worth LJ; Yong MK; Slavin MA; Teh BW
Med J Aust; 2020 Jun; 212(10):481-489. PubMed ID: 32401360
[TBL] [Abstract][Full Text] [Related]
15. BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.
Queiroz NSF; Teixeira FV; Freire CCF; Motta MP; Vasconcellos MAM; Chebli LA; Saad-Hossne R;
Arq Gastroenterol; 2021; 58(1):1-4. PubMed ID: 33909805
[TBL] [Abstract][Full Text] [Related]
16. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
17. Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer.
Kuderer NM; Hill JA; Carpenter PA; Lyman GH
Cancer Invest; 2021 Mar; 39(3):205-213. PubMed ID: 33534645
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of cancer patients against COVID-19: towards the end of a dilemma.
Mandal A; Singh P; Samaddar A; Singh D; Verma M; Rakesh A; Ranjan R
Med Oncol; 2021 Jul; 38(8):92. PubMed ID: 34235592
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Klimek L; Chaker AM; Cuevas M
Laryngorhinootologie; 2021 May; 100(5):344-354. PubMed ID: 33684947
[TBL] [Abstract][Full Text] [Related]
20. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]